✦ LIBER ✦

Production of genetically modified cells expressing specific transgenes by retroviral vectors for gene therapy

✍ Scribed by Jasodhara Ray; Fred H. Gage

Publisher: Springer
Year: 1993
Tongue: English
Weight: 952 KB
Volume: 15
Category: Article
ISSN: 1573-0603
DOI: 10.1007/bf01667370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endostatin- and interleukin-2-expressing

Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma

✍ Flávia Gomes de Góes Rocha; Fernanda B. Calvo; Karen C. Chaves; Jean P. S. Peron 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

## Abstract ## Background Metastatic renal cell carcinoma (mRCC) is one of the most treatment‐resistant malignancies. Despite all new therapeutic advances, almost all patients develop resistance to treatment and cure is rarely seen. In the present study, we evaluated the antitumor effect of a bici

Integration profile of retroviral vector

Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell

✍ Luca Biasco; Alessandro Ambrosi; Danilo Pellin; Cynthia Bartholomae; Immacolata 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

## Abstract The analysis of genomic distribution of retroviral vectors is a powerful tool to monitor ‘vector‐on‐host’ effects in gene therapy (GT) trials but also provides crucial information about ‘host‐on‐vector’ influences based on the target cell genetic and epigenetic state. We had the unique

Gene transfer and genetic modification o

Gene transfer and genetic modification of embryonic stem cells by Cre- and Cre-PR-expressing MESV-based retroviral vectors

✍ Stelios Psarras; Niki Karagianni; Christoph Kellendonk; François Tronche; Franço 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

## Abstract ## Background Genetic modification of embryonic stem (ES) cells represents a powerful tool for transgenic and developmental experiments. We report that retroviral constructs based on murine embryonal stem cell virus (MESV) can efficiently deliver and express Cre recombinase or a post‐t